Crinetics Pharmaceuticals, Inc. Gain (Loss) on Investments
Crinetics Pharmaceuticals, Inc. (CRNX) reported Gain (Loss) on Investments of -$997.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2023-11-07
- Crinetics Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2023-09-30 was -$997.00K.
- Crinetics Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2022-09-30 was $0.00.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 9 month |
|---|---|---|
| 2023-09-30 | -$997.00K 10-Q · filed 2023-11-07 | -$997.00K 10-Q · filed 2023-11-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | -$1.01M 10-Q · filed 2023-11-07 |